-
Mashup Score: 6AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study - PubMed - 5 day(s) ago
QuestionThe performance of artificial intelligence-based medical tools for prostate MRI has yet to be evaluated on multi-centre, multi-vendor data to assess generalisability. FindingsA dedicated AI medical tool matches the performance of multidisciplinary team-supported radiologists in prostate canc …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMA-negative relapse after CAR-T therapy - PubMed - 5 day(s) ago
Multiple myeloma (MM) relapse still occurs after a durable response to anti-BCMA chimeric antigen receptor-engineered T (CAR-T) cell therapy with less-defined factors. Herein, we investigated a CAR-T-exposed MM patient who relapsed after 12 months of remission by single-cell transcriptome sequencing …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
#Myeloma Paper of the Day: Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMA-negative relapse after CAR-T therapy, and ANXA1 inhibition may effectively diminish BCMA-negative myeloma: https://t.co/CClCmZCuik. #mmsm https://t.co/WjvAFXOXRC
-
-
Mashup Score: 6PubMed - 5 day(s) ago
PubMed® comprises more than 36 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, NephrologyTweet-
It feels we left 23' last #NephJC chronicles unspoken. Could it be just 22’ echo, or a retro party with all nephrologists for granted fav? 🥁Drumrolls, old masquerade, with veteran knight of many kidney battles Don't you ever stop rACEing 🏁 https://t.co/RVIlCuNdVz 37935833/ https://t.co/PCkVs4QtWl
-
-
Mashup Score: 0Restarting Teclistamab and Talquetamab after Prolonged Dose Delay May Not Require Re-Step-up Dosing - PubMed - 5 day(s) ago
Restarting Teclistamab and Talquetamab after Prolonged Dose Delay May Not Require Re-Step-up Dosing
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
Restarting Teclistamab and Talquetamab after Prolonged Dose Delay May Not Require Re-Step-up Dosing - the MSK experience #mmsm @BloodAdvances @MSKCancerCenter @MSK_DeptOfMed @CarlynRTanMD et al. https://t.co/KFhyLAz76z
-
-
Mashup Score: 0Left Atrial Mitral Valve Chordae Which Disturbed the Mitral Leaflet Motion and Induced Mitral Regurgitation - PubMed - 5 day(s) ago
Left atrial mitral valve chorda (LAMVC) is a rare congenital cardiac anomaly. The abnormal tissue band, like a mitral valve chorda, is attached to the left atrial wall on one side and mostly to the mitral valve leaflet on the other side and the band sometimes disturbs the mitral leaflet motion, foll …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Cardiac SurgeryTweet-
New article on Vol.31-1 Left Atrial Mitral Valve Chordae Which Disturbed the Mitral Leaflet Motion and Induced Mitral Regurgitation #cardiac https://t.co/U14vOWi60c https://t.co/SRnVRAia53
-
-
Mashup Score: 0
UVATS demonstrated favorable perioperative outcomes and comparable oncological efficacy to MVATS in the management of lobectomy and segmentectomy for lung cancer.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Cardiac SurgeryTweet-
New article on Vol.31-1 Outcomes of Uniportal Video-Assisted Thoracoscopic Surgery in the Management of Lobectomy and Segmentectomy for Lun… #VATS #lungcancer https://t.co/YjYNj3iHhO https://t.co/afQqzOQjZ8
-
-
Mashup Score: 0
In this study, several factors, mostly modifiable, were associated with a higher risk of YOD. These modifiable risk factors should be incorporated in future dementia prevention initiatives and raise new therapeutic possibilities for YOD.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, NeurologyTweet-
9/31 #BrainInjuryAwarenessMonth! #BIAM @BIRC_at_UCLA @UCLABrainSPORT #JC: @KevinBickart shares early #dementia risk-factors. Assocs include social isolation, vit D deficiency, cardiovascular dz... @patmchen @bill_flavin Hendriks S, ea, @JAMANeuro 2024: https://t.co/KlLSlKxz28 https://t.co/a3d2esfKGC
-
-
Mashup Score: 0-----Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma - PubMed - 6 day(s) ago
ACC1 is a metabolic vulnerability in MYC-driven MM. Inhibiting ACC1 disrupts lipid homeostasis, induces ER stress, and causes oxidative damage, impairing cell survival. Targeting lipid synthesis pathways, especially in MYC-dependent subtypes, offers a promising therapeutic strategy for MM.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
#Myeloma Paper of the Day: ACC1 (Acetyl-CoA carboxylase) is a metabolic vulnerability in MYC-driven myeloma & inhibiting ACC1 disrupts lipid homeostasis, induces ER stress, and causes oxidative damage, impairing cell survival: https://t.co/mCEP9fC6hy. #mmsm https://t.co/DdDomuXnm1
-
-
Mashup Score: 0
National Institutes of Health.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Infectious DiseaseTweet-
Potential Clinical and Economic Impacts of Cutbacks in the President's Emergency Plan for AIDS Relief Program in So… https://t.co/a5xI7avzkM
-
-
Mashup Score: 3
This study demonstrates that ATTRv should be investigated systematically in patients diagnosed with IVIg-NR CIDP. HCP-directed information campaigns are useful for modifying diagnostic practices.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
A very high-yield vignette CIDP that is resistant to typical treatments such as IVIg --> test for TTR variant In general, any polyneuropathy should lead to TTR gene variant testing Sponsored testing is free https://t.co/uLZjqO1LaJ #CardioTwitter https://t.co/hPlrJDhBuU
-
RT @APCCC_Lugano: AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study https://t.co/K0JIbFFglZ This study…